MedTrace Logo

Prospective Russian Evaluation of Lp(a) Role in cardiovascUlar DiseasE

NCT02515747 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1400

Last updated 2015-08-05

No results posted yet for this study

Summary

The purpose of this study is to explore the role of lipoprotein(a) and apolipoprotein(a) phenotype in fatal and non-fatal cardiovascular disease (CVD) events risk in coronary disease patients divided on the basis of management strategy - medical, endovascular or open cardiac surgery.

Conditions

Interventions

PROCEDURE

percutaneous coronary intervention

elective percutaneous coronary balloon angioplasty and/or stenting

PROCEDURE

coronary artery bypass grafting

elective surgical myocardial revascularisation

Sponsors & Collaborators

  • Russian Cardiology Research and Production Center

    lead OTHER

Principal Investigators

  • Marat V. Ezhov, PhD, DMSc · Russian Cardiology Research and Production Center

  • Sergei N. Pokrovsky, PhD, DSc · Russian Cardiology Research and Production Center

  • Valery V. Kukharchuk, PhD, DMSc · Russian Cardiology Research and Production Center

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1993-01-31
Primary Completion
2006-09-30
Completion
2014-01-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02515747 on ClinicalTrials.gov